iX Biopharma Ltd. announced on Jan, 29 2026 that it has issued 63,840 new ordinary shares after the exercise of warrants at an exercise price of 0.06 Singapore dollars each.

The move raises the company’s total share count to 959,424,245 from 959,360,405.

The newly issued shares will trade on the Singapore Exchange starting Feb, 2 2026 and rank pari passu with existing shares.

Overall, 4,464,800 warrants, or 7.76% of those originally issued, have now been exercised, leaving 53,044,679 warrants outstanding. These remaining warrants carry the same 0.06 Singapore-dollar exercise price and expire on Jul, 18 2026.